Stay updated on Dupilumab in Prurigo Nodularis: Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Prurigo Nodularis: Clinical Trial page.

Latest updates to the Dupilumab in Prurigo Nodularis: Clinical Trial page
- Check5 days agoChange DetectedThe Study Locations section was expanded to include numerous investigational sites in the US and internationally (Argentina, China, France, Japan, Mexico, Russia, South Korea, and more). This broadens recruitment geography.SummaryDifference2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded a note clarifying that publications are automatically filled from PubMed and may not be about the study, and updated the page revision to v3.3.2. The previous PubMed-focused note and revision text (v3.2.0) were removed.SummaryDifference0.1%

- Check41 days agoChange DetectedAdded a new publication citation to the Publications section (Kim BS et al., Am J Clin Dermatol, 2025) and removed a generic NIH funding status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check63 days agoChange DetectedAn updated last update timestamp and minor formatting changes are visible; core study details, eligibility criteria, locations, and outcomes remain unchanged.SummaryDifference0.3%

- Check84 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference2%

- Check91 days agoChange DetectedAdd: Revision: v3.1.0 to indicate a new version. Remove: several MedlinePlus topics and an earlier version tag (v3.0.2).SummaryDifference0.3%

Stay in the know with updates to Dupilumab in Prurigo Nodularis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Prurigo Nodularis: Clinical Trial page.